Is a complete CVKD research report available?

No complete published report is available for Cadrenal Therapeutics, Inc. (CVKD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Cadrenal Therapeutics, Inc. (CVKD)

NASDAQ: CVKD · USD

$0.92

-0.02 (-2.1%)· Recorded snapshot

Market cap	3.3M
Net income (ttm)	-11.5M
EPS (ttm)	-$4.86
Shares out	3.6M
Volume	35,899
Beta	1.95

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -11.5M
EPS (ttm): -$4.86
Market cap: 3.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Giữ

Metric	Value
Amount currency	USD
CIK code	0001937993
Company name	Cadrenal Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	127636207
Earnings date	2026-11-09
Earnings time	bmo
Employees	5
Employees change	1
Employees growth	25%
Enterprise value	$902,255
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2022
Industry	Biotechnology
IPO date	2023-01-20
Is primary listing	Yes
Is SPAC	No
ISIN number	US1276362076
Last 10-K release date	2026-03-31
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	2024-08-20
Last stock split type	Reverse
Market cap	$3.3M
Market cap category	Nano-Cap
Next earnings date	2026-11-09
Options	No
Price	$0.92
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	CVKD
U.S. state	Florida
Website	https://www.cadrenal.com

Metric

Value

Amount currency

USD

CIK code

0001937993

Company name

Cadrenal Therapeutics, Inc.

Country

United States

Country code

CUSIP number

127636207

Earnings date

2026-11-09

Earnings time

bmo

Employees

Employees change

Employees growth

25%

Enterprise value

$902,255

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2022

Industry

Biotechnology

IPO date

2023-01-20

Is primary listing

Yes

Is SPAC

ISIN number

US1276362076

Last 10-K release date

2026-03-31

Last earnings date

2026-08-13

Last refreshed

2026-10-28

Last stock split date

2024-08-20

Last stock split type

Reverse

Market cap

$3.3M

Market cap category

Nano-Cap

Next earnings date

2026-11-09

Options

Price

$0.92

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

CVKD

U.S. state

Florida

Website

https://www.cadrenal.com

Metric	Value
Earnings yield	-527.43%
FCF / EV yield	-1,043.99%
FCF yield	-302.35%
P/B ratio	0.71x
Price / tangible book value	0.82x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-527.43%

FCF / EV yield

-1,043.99%

FCF yield

-302.35%

P/B ratio

0.71x

Price / tangible book value

0.82x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Profit per employee	$-2.3M
ROA	-125.93%
ROCE	-284.81%
ROE	-275.16%
ROIC	-173.61%

Metric

Value

Profit per employee

$-2.3M

ROA

-125.93%

ROCE

-284.81%

ROE

-275.16%

ROIC

-173.61%

Metric	Value
EPS growth quarters	5
EPS growth years	3
Net income growth quarters	3
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-1,853
Depreciation and amortization	$2,015
EBIT	$-11.7M
EBITDA	$-11.7M
EPS	$-4.86
FCF per share	$-2.85
Financing cash flow	$7M
Free cash flow	$-10.2M
Free cash flow minus SBC	$-11.9M
Investing cash flow	$-412
Net cash flow	$-3.2M
Net income	$-11.5M
Operating cash flow minus SBC	$-11.9M
Operating income	$-11.7M
Stock-based compensation	$1.7M

Metric

Value

Capital expenditures

$-1,853

Depreciation and amortization

$2,015

EBIT

$-11.7M

EBITDA

$-11.7M

EPS

$-4.86

FCF per share

$-2.85

Financing cash flow

$7M

Free cash flow

$-10.2M

Free cash flow minus SBC

$-11.9M

Investing cash flow

$-412

Net cash flow

$-3.2M

Net income

$-11.5M

Operating cash flow minus SBC

$-11.9M

Operating income

$-11.7M

Stock-based compensation

$1.7M

Metric	Value
Book value per share	$1.32
Debt / equity	0
Long-term assets	$4,842
Long-term liabilities	$0
Net cash (debt)	$2.4M
Net cash / market cap	71.04%
Net cash growth	-57.13%
Net debt / equity	-0.58
Piotroski F-Score	2
Property, plant and equipment	$2,675
Shareholders' equity	$4.1M
Tangible book value	$4.1M
Tangible book value per share	$1.32
Total assets	$5.6M
Total cash	$2.4M
Total debt	$0
Total liabilities	$1.5M
WACC	14.98%

Metric

Value

Book value per share

$1.32

Debt / equity

Long-term assets

$4,842

Long-term liabilities

Net cash (debt)

$2.4M

Net cash / market cap

71.04%

Net cash growth

-57.13%

Net debt / equity

-0.58

Piotroski F-Score

Property, plant and equipment

$2,675

Shareholders' equity

$4.1M

Tangible book value

$4.1M

Tangible book value per share

$1.32

Total assets

$5.6M

Total cash

$2.4M

Total debt

Total liabilities

$1.5M

WACC

14.98%

Metric	Value
Current assets	$5.6M
Current liabilities	$1.5M
Current ratio	3.73
Net working capital	$1.7M
Quick ratio	3.39
Working capital	$4.1M

Metric

Value

Current assets

$5.6M

Current liabilities

$1.5M

Current ratio

3.73

Net working capital

$1.7M

Quick ratio

3.39

Working capital

$4.1M

Metric	Value
Buyback yield / dilution	-44.92%
Dividend yield	0%
Shareholder yield	-44.92%

Metric

Value

Buyback yield / dilution

-44.92%

Dividend yield

Shareholder yield

-44.92%

Metric	Value
150-day SMA	$3.00
1D price change	-2.12%
1M price change	-19.8%
1M total return	-19.8%
1W price change	-9.58%
1W total return	-9.58%
1Y price change	-92.96%
1Y return CAGR	-92.97%
1Y total return	-92.96%
20-day SMA	$0.97
200-day SMA	$4.02
3M price change	-55.23%
3M total return	-55.23%
3Y price change	-86.85%
3Y return CAGR	-49.14%
3Y total return	-86.85%
50-day SMA	$1.17
50-day SMA vs 200-day SMA	50under200
52-week high	$13.75
52-week high date	2025-10-31
52-week low	$0.82
52-week low date	2026-10-12
6M price change	-83.82%
6M total return	-83.82%
All-time high	$101.25
All-time high date	2023-01-20
All-time low	$0.82
All-time low date	2026-10-12
Average true range (ATR)	$0.11
Average volume	208K
Beta (1Y)	2.19
Beta (2Y)	0.97
Beta (5Y)	1.95
Change from 52-week high	-93.29%
Change from 52-week low	12.99%
Change from all-time high	-99.09%
Change from all-time low	12.99%
Change from open	-0.83%
Day's gap	-1.31%
Dollar volume	$33,110
High price	$0.93
Low price	$0.92
Monthly RSI	30.68
Open price	$0.93
Position in 52-week range	0%
Premarket change	12.49%
Premarket close	$0.94
Premarket price	$1.06
Previous close	$0.94
Price vs 150-day SMA	-69.23%
Price vs 20-day SMA	-5.07%
Price vs 200-day SMA	-77.06%
Price vs 50-day SMA	-20.97%
Relative volume	0.17
Return from IPO open	-98.9%
Return from IPO price	-81.15%
RSI	39.2
Sharpe ratio	-2.15
Sharpe ratio (3Y)	-0.25
Sortino ratio	-2.91
Sortino ratio (3Y)	-0.32
Volume	35.9K
Weekly RSI	25.16
YTD price change	-86.4%
YTD total return	-86.4%

Metric

Value

150-day SMA

$3.00

1D price change

-2.12%

1M price change

-19.8%

1M total return

-19.8%

1W price change

-9.58%

1W total return

-9.58%

1Y price change

-92.96%

1Y return CAGR

-92.97%

1Y total return

-92.96%

20-day SMA

$0.97

200-day SMA

$4.02

3M price change

-55.23%

3M total return

-55.23%

3Y price change

-86.85%

3Y return CAGR

-49.14%

3Y total return

-86.85%

50-day SMA

$1.17

50-day SMA vs 200-day SMA

50under200

52-week high

$13.75

52-week high date

2025-10-31

52-week low

$0.82

52-week low date

2026-10-12

6M price change

-83.82%

6M total return

-83.82%

All-time high

$101.25

All-time high date

2023-01-20

All-time low

$0.82

All-time low date

2026-10-12

Average true range (ATR)

$0.11

Average volume

208K

Beta (1Y)

2.19

Beta (2Y)

0.97

Beta (5Y)

1.95

Change from 52-week high

-93.29%

Change from 52-week low

12.99%

Change from all-time high

-99.09%

Change from all-time low

12.99%

Change from open

-0.83%

Day's gap

-1.31%

Dollar volume

$33,110

High price

$0.93

Low price

$0.92

Monthly RSI

30.68

Open price

$0.93

Position in 52-week range

Premarket change

12.49%

Premarket close

$0.94

Premarket price

$1.06

Previous close

$0.94

Price vs 150-day SMA

-69.23%

Price vs 20-day SMA

-5.07%

Price vs 200-day SMA

-77.06%

Price vs 50-day SMA

-20.97%

Relative volume

0.17

Return from IPO open

-98.9%

Return from IPO price

-81.15%

RSI

39.2

Sharpe ratio

-2.15

Sharpe ratio (3Y)

-0.25

Sortino ratio

-2.91

Sortino ratio (3Y)

-0.32

Volume

35.9K

Weekly RSI

25.16

YTD price change

-86.4%

YTD total return

-86.4%

Metric	Value
Float	3.2M
Float percentage	90.27%
Shares change (QoQ)	21%
Shares change (YoY)	44.92%
Shares held by insiders	9.73%
Shares held by institutions	10.41%
Shares outstanding	3.6M
Short % of float	3.29%
Short % of shares	2.97%
Short ratio	0.1 days

Metric

Value

Float

3.2M

Float percentage

90.27%

Shares change (QoQ)

21%

Shares change (YoY)

44.92%

Shares held by insiders

9.73%

Shares held by institutions

10.41%

Shares outstanding

3.6M

Short % of float

3.29%

Short % of shares

2.97%

Short ratio

0.1 days

Cadrenal Therapeutics, Inc. (CVKD)

Price

Financial snapshot

Fair-value bridge

Latest news · CVKD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CVKD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CVKD

Frequently asked questions